Document is current
Any future updates will be listed below
-
Authors
Ma, Min
Ren, Qian
Fujita, Yuko
Yang, Chun
Dong, Chao
Ohgi, Yuta
Futamura, Takashi
Hashimoto, Kenji
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical
Japan Agency for Medical Research and Development
- License Information
-
More Information
Article History
Received: 11 April 2017
Accepted: 17 July 2017
First Online: 26 July 2017
Compliance with ethical standards
: The study was approved by the Animal Care and Use Committee of Chiba University Graduate School of Medicine.
: Dr. Hashimoto is an inventor on a filed patent application on “The use of R-ketamine in the treatment of psychiatric diseases” by Chiba University. Dr. Hashimoto received research support from Dainippon-Sumitomo, Mochida, Otsuka, and Taisho. Dr. Ohgi and Dr. Futamura are employees of Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan). Other authors declare no conflict of interest.
